Literature DB >> 12642098

Nuclear export of influenza viral ribonucleoprotein is temperature-dependently inhibited by dissociation of viral matrix protein.

Atsushi Sakaguchi1, Etsuko Hirayama, Akihiro Hiraki, Yo-ichi Ishida, Jeman Kim.   

Abstract

The influenza virus copies its genomic RNA in the nuclei of host cells, but the viral particles are formed at the plasma membrane. Thus, the export of new genome from the nucleus into the cytoplasm is essential for viral production. Several viral proteins, such as nucleoprotein (NP) and RNA polymerases, synthesized in the cytoplasm, are imported into the nucleus, and form viral ribonucleoprotein (vRNP) with new genomic RNA. vRNP is then exported into the cytoplasm from the nucleus to produce new viral particles. M1, a viral matrix protein, is suggested to participate in the nuclear export of vRNP. It was found unexpectedly that the production of influenza virus was suppressed in MDCK cells at 41 degrees C, although viral proteins were synthesized and the cytopathic effect was observed in host cells. Indirect immunofluorescent staining with anti-NP or M1 monoclonal antibody showed that NP and M1 remained in the nuclei of infected cells at 41 degrees C, suggesting that a suppression of viral production was caused by inhibition of the nuclear export of these proteins. The cellular machinery for nuclear export depending on CRM1, which mediates the nuclear export of influenza viral RNP, functioned normally at 41 degrees C. Glycerol-density gradient centrifugation demonstrated that vRNP also formed normally at 41 degrees C. However, an examination of the interaction between vRNP and M1 by immunoprecipitation indicated that M1 did not associate with vRNP at 41 degrees C, suggesting that the association is essential for the nuclear export of vRNP. Furthermore, when infected cells incubated at 41 degrees C were cultured at 37 degrees C, the interaction between vRNP and M1 was no longer detected even at 37 degrees C. The results suggest that M1 synthesized at 41 degrees C is unable to interact with vRNP and the dissociation of M1 from vRNP is one of the reasons that the transfer of vRNP into the cytoplasm from the nucleus is prevented at 41 degrees C.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12642098     DOI: 10.1016/s0042-6822(02)00013-2

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  13 in total

1.  Human immunodeficiency virus rev-binding protein is essential for influenza a virus replication and promotes genome trafficking in late-stage infection.

Authors:  Amie J Eisfeld; Gabriele Neumann; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2011-07-13       Impact factor: 5.103

2.  RAB11A is essential for transport of the influenza virus genome to the plasma membrane.

Authors:  Amie J Eisfeld; Eiryo Kawakami; Tokiko Watanabe; Gabriele Neumann; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2011-04-27       Impact factor: 5.103

3.  The role of aldehyde dehydrogenase and hsp70 in suppression of white spot syndrome virus replication at high temperature.

Authors:  Ying-Ru Lin; Hsiao-Chun Hung; Jiann-Horng Leu; Hao-Ching Wang; Guang-Hsiung Kou; Chu-Fang Lo
Journal:  J Virol       Date:  2011-01-12       Impact factor: 5.103

4.  The compensatory G88R change is essential in restoring the normal functions of influenza A/WSN/33 virus matrix protein 1 with a disrupted nuclear localization signal.

Authors:  Hang Xie; Zhengshi Lin; Philip D Mosier; Umesh R Desai; Yamei Gao
Journal:  J Virol       Date:  2012-10-17       Impact factor: 5.103

Review 5.  At the centre: influenza A virus ribonucleoproteins.

Authors:  Amie J Eisfeld; Gabriele Neumann; Yoshihiro Kawaoka
Journal:  Nat Rev Microbiol       Date:  2014-11-24       Impact factor: 60.633

6.  Heat shock protein 70 is related to thermal inhibition of nuclear export of the influenza virus ribonucleoprotein complex.

Authors:  Etsuko Hirayama; Hiromitsu Atagi; Akihiro Hiraki; Jeman Kim
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

7.  Sulfatide is required for efficient replication of influenza A virus.

Authors:  Tadanobu Takahashi; Kouki Murakami; Momoe Nagakura; Hideyuki Kishita; Shinya Watanabe; Koichi Honke; Kiyoshi Ogura; Tadashi Tai; Kazunori Kawasaki; Daisei Miyamoto; Kazuya I P J Hidari; Chao-Tan Guo; Yasuo Suzuki; Takashi Suzuki
Journal:  J Virol       Date:  2008-04-16       Impact factor: 5.103

8.  Pretreatment with recombinant human vascular endothelial growth factor reduces virus replication and inflammation in a perinatal lamb model of respiratory syncytial virus infection.

Authors:  David K Meyerholz; Jack M Gallup; Tatjana Lazic; Marcia M A de Macedo; Howard D Lehmkuhl; Mark R Ackermann
Journal:  Viral Immunol       Date:  2007       Impact factor: 2.257

9.  Inferring Protein Function in an Emerging Virus: Detection of the Nucleoprotein in Tilapia Lake Virus.

Authors:  Reem Abu Rass; Talia Kustin; Rachel Zamostiano; Nechama Smorodinsky; Daniella Ben Meir; Daniel Feder; Nischay Mishra; W Ian Lipkin; Avi Eldar; Marcelo Ehrlich; Adi Stern; Eran Bacharach
Journal:  J Virol       Date:  2022-02-02       Impact factor: 6.549

10.  Temperature sensitive influenza A virus genome replication results from low thermal stability of polymerase-cRNA complexes.

Authors:  Rosa M Dalton; Anne E Mullin; Maria Joao Amorim; Elizabeth Medcalf; Laurence S Tiley; Paul Digard
Journal:  Virol J       Date:  2006-08-25       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.